Evolent Health, Inc. EVH Reportable segment — Medical expense and device costs

Similar metrics at other companies

ALHCReportable Segment — Medical expenses

$1.09B+32.9%

ALHCReportable Segment — Other segment expenses

$21.91M-11.8%

GRALReportable Segment — Total Costs & Expenses

$176.55M-4.8%

TNETReportable Segment — Health insurance costs

$833M-9.4%

TASKReportable Segment — Total Costs & Expenses

$272.06M+11.7%

CTEVReportable Segment — Total Costs & Expenses

$238.04M+7.4%

Questions, answered.

What is Evolent Health, Inc.'s reportable segment — medical expense and device costs?

Evolent Health, Inc. (EVH) reported reportable segment — medical expense and device costs of $335.36M in Q1 2026.

How has Evolent Health, Inc.'s reportable segment — medical expense and device costs changed year-over-year?

Evolent Health, Inc.'s reportable segment — medical expense and device costs increased by 14.6% year-over-year, from $292.68M to $335.36M.

What is the long-term trend for Evolent Health, Inc.'s reportable segment — medical expense and device costs?

Over 3 years (2022 to 2025), Evolent Health, Inc.'s reportable segment — medical expense and device costs has grown at a 14.8% compound annual growth rate (CAGR), from $725.04M to $1.1B.

What does reportable segment — medical expense and device costs mean?

These are the direct costs incurred by the segment related to patient care, medical services, and necessary medical devices. Monitoring these costs is essential for assessing the segment's ability to manage total cost of care effectively within value-based arrangements.